ASPN and triple-negative breast carcinoma: The results indicated that tumorigenic and highly metastatic triple-negative breast cancer (TNBC) cells of the basal-like subtype (e.g., MDA-MB-231 and MDA-MB-468) [33–35] did not induce asporin expression in NBFs.